David DeShazer
Bacteriology Division
United States Army Medical Research Institute of Infectious Diseases
David DeShazer has not added Biography.
If you are David DeShazer and would like to personalize this page please email our Author Liaison for assistance.
Nonviable Burkholderia mallei induces a mixed Th1- and Th2-like cytokine response in BALB/c mice.
Infection and immunity May, 2002 | Pubmed ID: 11953366
Burkholderia thailandensis E125 harbors a temperate bacteriophage specific for Burkholderia mallei.
Journal of bacteriology Jul, 2002 | Pubmed ID: 12081973
Type III secretion: a virulence factor delivery system essential for the pathogenicity of Burkholderia mallei.
Infection and immunity Feb, 2004 | Pubmed ID: 14742564
Genomic diversity of Burkholderia pseudomallei clinical isolates: subtractive hybridization reveals a Burkholderia mallei-specific prophage in B. pseudomallei 1026b.
Journal of bacteriology Jun, 2004 | Pubmed ID: 15175308
Role of quorum sensing in the pathogenicity of Burkholderia pseudomallei.
Journal of medical microbiology Nov, 2004 | Pubmed ID: 15496380
Quorum sensing: a transcriptional regulatory system involved in the pathogenicity of Burkholderia mallei.
Infection and immunity Nov, 2004 | Pubmed ID: 15501791
Aerogenic vaccination with a Burkholderia mallei auxotroph protects against aerosol-initiated glanders in mice.
Vaccine Mar, 2005 | Pubmed ID: 15734072
Development of a polymerase chain reaction assay for the specific identification of Burkholderia mallei and differentiation from Burkholderia pseudomallei and other closely related Burkholderiaceae.
Diagnostic microbiology and infectious disease May, 2006 | Pubmed ID: 16546342
Polysaccharide microarray technology for the detection of Burkholderia pseudomallei and Burkholderia mallei antibodies.
Diagnostic microbiology and infectious disease Nov, 2006 | Pubmed ID: 16765554
Genome sequence alterations detected upon passage of Burkholderia mallei ATCC 23344 in culture and in mammalian hosts.
BMC genomics Sep, 2006 | Pubmed ID: 16953889
Virulence of clinical and environmental isolates of Burkholderia oklahomensis and Burkholderia thailandensis in hamsters and mice.
FEMS microbiology letters Dec, 2007 | Pubmed ID: 17986086
Comparative genomics and an insect model rapidly identify novel virulence genes of Burkholderia mallei.
Journal of bacteriology Apr, 2008 | Pubmed ID: 18223084
Burkholderia mallei cluster 1 type VI secretion mutants exhibit growth and actin polymerization defects in RAW 264.7 murine macrophages.
Infection and immunity Jan, 2010 | Pubmed ID: 19884331
Burkholderia thailandensis oacA mutants facilitate the expression of Burkholderia mallei-like O polysaccharides.
Infection and immunity Feb, 2011 | Pubmed ID: 21115721
The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei.
Infection and immunity Apr, 2011 | Pubmed ID: 21300775
Humoral immune responses in a human case of glanders.
Clinical and vaccine immunology : CVI May, 2012 | Pubmed ID: 22398248
The Madagascar hissing cockroach as a novel surrogate host for Burkholderia pseudomallei, B. mallei and B. thailandensis.
BMC microbiology Jun, 2012 | Pubmed ID: 22892068
Characterization of the Burkholderia thailandensis SOS response by using whole-transcriptome shotgun sequencing.
Applied and environmental microbiology Oct, 2013 | Pubmed ID: 23872555
A high-content imaging assay for the quantification of the Burkholderia pseudomallei induced multinucleated giant cell (MNGC) phenotype in murine macrophages.
BMC microbiology , 2014 | Pubmed ID: 24750902
Proteomic analysis of the Burkholderia pseudomallei type II secretome reveals hydrolytic enzymes, novel proteins, and the deubiquitinase TssM.
Infection and immunity Aug, 2014 | Pubmed ID: 24866793
The chemical arsenal of Burkholderia pseudomallei is essential for pathogenicity.
Journal of the American Chemical Society Jul, 2014 | Pubmed ID: 24884988
Melioidosis: molecular aspects of pathogenesis.
Expert review of anti-infective therapy Dec, 2014 | Pubmed ID: 25312349
pH Alkalinization by Chloroquine Suppresses Pathogenic Burkholderia Type 6 Secretion System 1 and Multinucleated Giant Cells.
Infection and immunity Jan, 2017 | Pubmed ID: 27799332
Development of Subunit Vaccines that Provide High Level Protection and Sterilizing Immunity Against Acute Inhalational Melioidosis.
Infection and immunity Nov, 2017 | Pubmed ID: 29109172
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved